ATR and neoplasm: Whilst the majority of these studies have focused on utilising clonogenic assays as an end-point, the ATR inhibitor AZD6738 was shown to impede the growth of 3D spheroids of hypopharyngeal (FaDu) cells in combination with radiation, which are more representative of the original tumour in vivo [21].